|
The device was not returned for analysis.Production record and corrective and preventative actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a query of the complaint handling database for the reported lot revealed there is no indication of a lot specific issue.Based on the information received, the investigation determined that the reported complaints appear to be related to circumstances of the procedure.There were no leaks noted during preparation, which suggests that a product quality issue did not contribute to the reported difficulties.In this case, based on the reported information, resistance was noted during advancement likely due to challenging anatomical conditions.It is likely that the balloon material was damaged during advancement resulting in rupture during inflation.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|
|
It was reported the 2.50 x 15mm nc trek neo rx was to be used in the distal right coronary artery (drca) with resistance between the balloon and the lesion.However, the nc trek ruptured at 11 atmospheres (atm) during the first inflation.Therefore, the nc trek was removed and another trek balloon was used to complete the procedure.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
|